Regeneron Pharmaceuticals · Other Income/Expenses (Net)

Latest reported$1.20Bperiod endingJun 30, 2026

REGN Other Income/Expenses (Net) ($3.30M → $1.20B)

Annual Other Income/Expenses (Net)

High-resolution chart · PNG

REGN other income/expenses (net) history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Regeneron Pharmaceuticals Other Income/Expenses (Net) — Annual fiscal periods (USD)
Period ending	Other Income/Expenses (Net) (USD)
Dec 31, 2025	1,652,800,000
Dec 31, 2024	789,200,000
Dec 31, 2023	-149,300,000
Dec 31, 2022	-526,800,000
Dec 31, 2021	379,000,000
Dec 31, 2020	233,800,000
Dec 31, 2019	219,300,000
Dec 31, 2018	19,100,000
Dec 31, 2017	-1,080,000
Dec 31, 2016	-926,000
Dec 31, 2015	-26,819,000
Dec 31, 2014	-62,684,000
Dec 31, 2013	-47,168,000
Dec 31, 2012	-46,092,000
Dec 31, 2011	-17,733,000
Dec 31, 2010	-6,996,000
Dec 31, 2009	2,151,000
Dec 31, 2008	9,471,000
Dec 31, 2007	8,854,000
Dec 31, 2006	4,157,000
Dec 31, 2005	26,762,000
Dec 31, 2004	36,053,000
Dec 31, 2003	-7,470,000
Dec 31, 2002	-2,424,000
Dec 31, 2001	9,503,000
Dec 31, 2000	25,276,000
Dec 31, 1999	23,800,000
Dec 31, 1998	12,500,000
Dec 31, 1997	6,200,000
Dec 31, 1996	0
Dec 31, 1995	0
Dec 31, 1994	29,200,000
Dec 31, 1993	38,800,000
Dec 31, 1992	18,300,000
Dec 31, 1991	0
Dec 31, 1990	3,300,000